[On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D013890:Thiourea / Q000627:therapeutic use; D014373:Tuberculin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D013450:Sulfones; D013882:Thiosemicarbazones; D014373:Tuberculin; D003622:Dapsone; D013890:Thiourea; D005000:Ethionamide; D007538:Isoniazid
Sur la chimiorésistance du bacille de Hansen et le traitement de la lèpre par des associations médicamenteuses.